Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP222610.RAE__pq4Cn0hd6ul0hbjI3bKPxKUIBdiDAhFacXB1Vxr0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP222610.RAE__pq4Cn0hd6ul0hbjI3bKPxKUIBdiDAhFacXB1Vxr0130_assertion type Assertion NP222610.RAE__pq4Cn0hd6ul0hbjI3bKPxKUIBdiDAhFacXB1Vxr0130_head.
- NP222610.RAE__pq4Cn0hd6ul0hbjI3bKPxKUIBdiDAhFacXB1Vxr0130_assertion description "[The survival calculated for the two groups of AML cases subdivided according to ADA levels was significantly longer (p less than 0.025) for the patients with low levels of ADA (less than 250 U/10(8) cells).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP222610.RAE__pq4Cn0hd6ul0hbjI3bKPxKUIBdiDAhFacXB1Vxr0130_provenance.
- NP222610.RAE__pq4Cn0hd6ul0hbjI3bKPxKUIBdiDAhFacXB1Vxr0130_assertion evidence source_evidence_literature NP222610.RAE__pq4Cn0hd6ul0hbjI3bKPxKUIBdiDAhFacXB1Vxr0130_provenance.
- NP222610.RAE__pq4Cn0hd6ul0hbjI3bKPxKUIBdiDAhFacXB1Vxr0130_assertion SIO_000772 7049266 NP222610.RAE__pq4Cn0hd6ul0hbjI3bKPxKUIBdiDAhFacXB1Vxr0130_provenance.
- NP222610.RAE__pq4Cn0hd6ul0hbjI3bKPxKUIBdiDAhFacXB1Vxr0130_assertion wasDerivedFrom befree-20150227 NP222610.RAE__pq4Cn0hd6ul0hbjI3bKPxKUIBdiDAhFacXB1Vxr0130_provenance.
- NP222610.RAE__pq4Cn0hd6ul0hbjI3bKPxKUIBdiDAhFacXB1Vxr0130_assertion wasGeneratedBy ECO_0000203 NP222610.RAE__pq4Cn0hd6ul0hbjI3bKPxKUIBdiDAhFacXB1Vxr0130_provenance.